This morning I got fed up of waiting for Hargreaves Lansdown to process my bed & ISA order, so I loaded £1,500 into my ISA from my current account, sold my share account holding of AMYT:Amryt Pharma and bought the same value in my ISA. As soon as the settlement clears I'll transfer the cash from my share account back to my bank account.
It was a little costly, but tolerable. I made £242.63 profit on the sale, including the buying and selling commission. I sold 6,882 shares at 22.04p making £1,504.84. I bought 6,507 shares at 22.87p costing £1,500.10. So the spread cost me 375 shares, which would be worth £82, but given the price promptly zoomed up to 24p, I gained £73 and still had £4 left over from the sale, so I'm only £5 down on the day, and any profits are now protected from tax.
The best news is that the profit from the sale pushed my average monthly performance up to 9.9% so it won't take much to get back to my 10% target. I know it's a fake addition to profit as I've bought the same shares back again, but those are my accounting rules so it's OK.
My overall AMYT:Amryt Pharma holding is now 33,813 shares, all of which are in my ISA. That's 10.5% of my combined portfolios. After today's 11.4% rise they are making paper profit of £1,769, which is my second best performing share after Star Share IQE:IQE, currently on £2,726 potential profit.
It's not been a great week so far, with OPTI:Optibiotix dropping below 70p and making me wish I had spare cash to buy more, and KIBO:Kibo Mining falling to 4.5p. The £1,167 I lost selling AFG:Aquatic Food on Monday boosted my paper profits by the same amount, but I've lost the £242 from selling the AMYT:Amryt Pharma shares today, and £408 from the rest of the portfolio since then.
Now AFG:Aquatic Food is out of the picture, it's a head-to-head race between OPTI:Optibiotix and KIBO:Kibo Mining for Nemesis Share. At the moment OPTI:Optibiotix is winning, with a paper loss of £1,217 as opposed to KIBO:Kibo Mining losing £1,169. What's most frustrating is both these shares have me locked in and unable to sell because of the promise of free shares in spun-off companies, but neither have said when the qualification date is for the shares. I really hope it's in the past, as I'll be terribly, terribly vexed if day traders get to buy in to hit a record date after I've been holding faithfully all this time. These are both long-term shares anyway, but I have holdings in them both outside my ISA that I want to move in, but can't risk missing the record date as a result. I wish they'd get a move on and tell shareholders what's going on.
Tomorrow sees SXX:Sirius Minerals move from AIM to the main market. I don't know if that's going to help the share price or whether it's already priced in. My recent purchase is 1% up with potential profit of £8 now I've got rid of spread and commission. I really hope there isn't a big sell-off tomorrow else my end of week will be a sorry tale. I have a feeling it's going to be a sorry tale anyway, as OPTI:Optibiotix isn't going to improve until after the launch of the cholesterol product in May, and KIBO:Kibo Mining needs some big news to recover from these lows. That never happens on a Friday, so I fear my portfolio value will take a hit this week.
Thursday 27 April 2017
Monday 24 April 2017
Massive loss on Aquatic Food
Over the weekend I took a long hard look at AFG:Aquatic Food. I read and re-read their recent trading update and I tried to be dispassionate. Up till now I've been reluctant to lose £1,100 but after my deliberations, I decided I was in fact rescuing £900.
These were my main reasons from the Q4 trading statement for coming to the conclusion that the risk of AFG:Aquatic Food being a fraud are too high to leave my money invested there
I really, really hope they turn out to be a real company for the sake of those brave enough to tough it out. I cracked, but have learned a very valuable lesson that if something looks too good to be true, there's probably a reason.
The sale hammered my average monthly performance, dropping from £393 a month to £337 and taking the average percentage profit below my 10% target to 9.7%. I'm hoping the profits from bedding shares into my ISA will take me back over my target, if Hargreaves Lansdown ever pull their finger out and process the orders.
I used the liberated cash to get back into SXX:Sirius Minerals as they move from AIM to the main market on Friday. I wanted to get back in earlier but had no cash, and paid the price as shares have risen from about 17p to 25p over the last 4 weeks, following news of the move to the main market. I'm buying for the long term when they join the FTSE 250. I bought 3,949 shares at 25.1875p costing £1,006.60.
The removal of a heavy loss share did help my paper profits, which immediately leapt by the £1,167 I lost from the sale. Unfortunately my portfolio lost £40 today despite lots of blue on most of the shares. Big drops for OPTI:Optibiotix (WHY?!?!?!?!) and KIBO:Kibo Mining wiped out all the little gains.
Tomorrow could be very interesting, with OPTI:Optibiotix giving final results and revealing how well the Go Figure sales are performing. REDS:RedstoneConnect are also posting final results. Any profit could see me able to sell the shares in my trading account and pay that bloody Visa bill...
These were my main reasons from the Q4 trading statement for coming to the conclusion that the risk of AFG:Aquatic Food being a fraud are too high to leave my money invested there
- The update was very downbeat despite the profits being quite good
- There was a remark about having difficulty getting cash out of China to pay the dividend
- There was a statement about holding onto the huge pile of cash as it was prudent in times of uncertainty, but with no threads of hope to shareholders of restoring the value of the dividend or investing in anything
- The director responsible for the IPO has launched other Chinese companies that subsequently de-listed and has now departed the company
- The market cap is a third of the cash pile they have, but still investors are leaving them
- Despite China supposedly taking a stricter stance on companies listing on AIM, de-valuing the shares and then de-listing, it's still happening, with companies like Taihua, Jiasen and MoneySwap all de-listing under dodgy circumstances recently.
I really, really hope they turn out to be a real company for the sake of those brave enough to tough it out. I cracked, but have learned a very valuable lesson that if something looks too good to be true, there's probably a reason.
The sale hammered my average monthly performance, dropping from £393 a month to £337 and taking the average percentage profit below my 10% target to 9.7%. I'm hoping the profits from bedding shares into my ISA will take me back over my target, if Hargreaves Lansdown ever pull their finger out and process the orders.
I used the liberated cash to get back into SXX:Sirius Minerals as they move from AIM to the main market on Friday. I wanted to get back in earlier but had no cash, and paid the price as shares have risen from about 17p to 25p over the last 4 weeks, following news of the move to the main market. I'm buying for the long term when they join the FTSE 250. I bought 3,949 shares at 25.1875p costing £1,006.60.
The removal of a heavy loss share did help my paper profits, which immediately leapt by the £1,167 I lost from the sale. Unfortunately my portfolio lost £40 today despite lots of blue on most of the shares. Big drops for OPTI:Optibiotix (WHY?!?!?!?!) and KIBO:Kibo Mining wiped out all the little gains.
Tomorrow could be very interesting, with OPTI:Optibiotix giving final results and revealing how well the Go Figure sales are performing. REDS:RedstoneConnect are also posting final results. Any profit could see me able to sell the shares in my trading account and pay that bloody Visa bill...
Friday 21 April 2017
Week 89 Review - Misery and woe
Last week I wrote "Oh unparalleled joy! The green line crashes spectacularly through the
red. I don't care how long it stays there - I should frame this and put
it on my bedroom wall so I always remember how happy I am right now."
The phrase "I don't care how long it stays there" is the painful one, and clearly bollocks. I did care very deeply, which is why I'm sunk into abject misery today as I look at a portfolio that has lost £2,532 of its value in just 4 trading days. The combined value is now £62,513 so I've also lost the 2 "Woohoo!"s from last week. I'm still £1,291 in the black so it could have been worse, but a lot of my buffer has been used up.
The biggest loser this week was the main reason I was so happy last week. Most of the gains vanished for AMYT:Amryt Pharma as a stampede of profit-taking broke out. This was the first time the price had gone above the reverse takeover price, but the sell-off was extreme and caused a 20% drop in the value of my shares.
The other double-digit loser was IQE:IQE dropping 12%, and as one of my other big holdings costing quite a lot. I rather think this was tree-shake behaviour triggering a whole load of stop-losses set to preserve profits. Interesting that every day this happened, all the forced sales were hoovered up. This demonstrates the danger of stop-losses on a volatile share, although if your timing was good you could get back in 12% cheaper. I bet not many people's timing is that good so I'd rather not risk it.
The other losses were less than 10% but for big shares in my portfolio like OPTI:Optibiotix, KIBO:Kibo Mining and CWR:Ceres Power.
There were no double digit risers to counter the drops. The biggest riser was TLOU:Tlou Energy, and that was only 4%.
I didn't want to see that shape.
The ISA and share accounts look like this
Crushing loss of £2,105 and £1,569 of this was reduction in potential profits. My attempt to bed and ISA AMYT:Amryt Pharma and JLP:Jubilee Platinum failed again as Hargreaves Lansdown didn't process the order. I may have to contact them, as the last thing I want is to leave the order open and find they've executed at a time of volatility that could be very costly. When I do this, the average monthly performance will improve, but I'll take a hit on paper value which could take me into the red.
I guess I could load the money from my bank account into my ISA for AMYT:Amryt Pharma as it's £1,500, then return the money to my account after the 3 day settling period from the sale. I can't do the same with JLP:Jubilee Platinum as the shares are worth £4,000, which would bust my overdraft. I suppose I could extend the overdraft to allow for it, as it's only 3 days. Last year Hargreaves Lansdown were really quick with bedding into the ISA, so I don't understand why they are so rubbish this year.
Boo hoo hoo hoo hoooooo.
The SIPP looks like this after week 73
Nowhere near as bad as the other accounts, but the second week in a row with a decline. Not much else going on.
Worrying - very worrying.
The dreaded trading account looks like this after week 39
Could have been a lot worse, with tiny dips in all shares. No chance of flogging KIBO:Kibo Mining to help pay my Visa bill though. At least 5.5% is a better return than I'd get from a savings account - although with 13 weeks to go before this account has been open a year, this figure is projected rather than real.
There's nothing to like with this graph.
I don't think I can blame the calling of the snap election for much of my losses this week. IQE:IQE rely on exchange rates at the moment, so a strengthening pound is bad for them, but I think the potential growth in revenues will offset the exchange rate issue. The good news is that TW.:Taylor Wimpey came withing a few quid of going into profit. Nearly a year after Brexit the price has almost recovered and are dishing out big dividends.
The drop in AMYT:Amryt Pharma shouldn't have been a surprise really. The drop in OPTI:Optibiotix was a massive surprise. Long term holders with spare cash are overjoyed they can add a load more to their ISAs. Tragically I don't have either the cash or any shares I want to sell, so all I can do is watch.
Most intriguing event this week is the news that AFPO:African Potash have suspended their shares on the NEX Exchange as they have announced their intention to buy out private company Onshore Energy Ltd. How the hell? They have no money - they have to pay the directors salaries in shares! I guess I shouldn't be too bothered. At the moment my shares are utterly worthless so things couldn't get worse. If this causes something interesting to happen then what the hell. The fact that Executive Chair Chris Cleverly is a director and shareholder of Onshore Energy is a bit of a worry though. The news also confirms there will be fundraising to make the purchase and cover existing running costs. I'm unable to be anything other than suspicious of this company and it's directors, so will watch with an air of skeptical cynicism.
Hope next week isn't as horrid as this one...
The phrase "I don't care how long it stays there" is the painful one, and clearly bollocks. I did care very deeply, which is why I'm sunk into abject misery today as I look at a portfolio that has lost £2,532 of its value in just 4 trading days. The combined value is now £62,513 so I've also lost the 2 "Woohoo!"s from last week. I'm still £1,291 in the black so it could have been worse, but a lot of my buffer has been used up.
The biggest loser this week was the main reason I was so happy last week. Most of the gains vanished for AMYT:Amryt Pharma as a stampede of profit-taking broke out. This was the first time the price had gone above the reverse takeover price, but the sell-off was extreme and caused a 20% drop in the value of my shares.
The other double-digit loser was IQE:IQE dropping 12%, and as one of my other big holdings costing quite a lot. I rather think this was tree-shake behaviour triggering a whole load of stop-losses set to preserve profits. Interesting that every day this happened, all the forced sales were hoovered up. This demonstrates the danger of stop-losses on a volatile share, although if your timing was good you could get back in 12% cheaper. I bet not many people's timing is that good so I'd rather not risk it.
The other losses were less than 10% but for big shares in my portfolio like OPTI:Optibiotix, KIBO:Kibo Mining and CWR:Ceres Power.
There were no double digit risers to counter the drops. The biggest riser was TLOU:Tlou Energy, and that was only 4%.
I didn't want to see that shape.
The ISA and share accounts look like this
| Weekly Change | |||
| Portfolio cost | £42,964.02 | +£0 | |
| Portfolio sell value (bid price - commission) | £41,665.86 | (-3%) | -£2,105.19 |
| Potential profits | £4,390.03 | -£1,569.02 | |
| Yr 2 Dividends | £357.10 | +£0 | |
| Yr 2 Profit from sales | £3,314.79 | +£0 | |
| Yr 2 Average monthly cash profit | £426.53 | -£11.85 | |
| Yr 2 Avg annual % of current portfolio cost | 11.9% | ||
| Total Dividends | £1,025.03 | +£0 | |
| Total Profit from sales | £7,155.05 | +£0 | |
| Average monthly cash profit | £393.88 | -£4.48 | |
| (Sold stocks profit + Dividends - Fees / Months) | |||
| Avg annual % of current portfolio cost | 11.0% |
Crushing loss of £2,105 and £1,569 of this was reduction in potential profits. My attempt to bed and ISA AMYT:Amryt Pharma and JLP:Jubilee Platinum failed again as Hargreaves Lansdown didn't process the order. I may have to contact them, as the last thing I want is to leave the order open and find they've executed at a time of volatility that could be very costly. When I do this, the average monthly performance will improve, but I'll take a hit on paper value which could take me into the red.
I guess I could load the money from my bank account into my ISA for AMYT:Amryt Pharma as it's £1,500, then return the money to my account after the 3 day settling period from the sale. I can't do the same with JLP:Jubilee Platinum as the shares are worth £4,000, which would bust my overdraft. I suppose I could extend the overdraft to allow for it, as it's only 3 days. Last year Hargreaves Lansdown were really quick with bedding into the ISA, so I don't understand why they are so rubbish this year.
Boo hoo hoo hoo hoooooo.
The SIPP looks like this after week 73
| Weekly Change | |||
| Portfolio cost | £16,776.69 | +£0 | |
| Portfolio sell value (bid price - commission) | £19,506.78 | (+16.3%) | -£403.23 |
| Potential profits | £3,499.80 | -£263.43 | |
| Yr 2 Dividends | £0 | +£0 | |
| Yr 2 Profit from sales | £842.07 | +£0 | |
| Yr 2 Average monthly cash profit | £166.41 | -£8.32 | |
| Yr 2 Avg annual % of current portfolio cost | 11.9% | ||
| Total Dividends | £413.19 | +£0 | |
| Total Profit from sales | £3,191.93 | +£0 | |
| Average monthly cash profit | £208.88 | -£2.90 | |
| (Sold stocks profit + Dividends - Fees / Months) | |||
| Avg annual % of current portfolio cost | 14.9% |
Nowhere near as bad as the other accounts, but the second week in a row with a decline. Not much else going on.
The dreaded trading account looks like this after week 39
| Weekly Change | |||
| Portfolio cost | £1,481.98 | +£0 | |
| Cash | £79.63 | +£0 | |
| Portfolio sell value (bid price - commission) | £1,341.27 | (-9.5%) | -£24.16 |
| Potential profits | £0 | +£0 | |
| Dividends | £0 | +£0 | |
| Profit from sales | £61.57 | +£0 | |
| Average monthly cash profit | £6.84 | -£0.18 | |
| (Sold stocks profit + Dividends - Fees / Months) | |||
| Avg annual % of current portfolio cost | 5.5% |
Could have been a lot worse, with tiny dips in all shares. No chance of flogging KIBO:Kibo Mining to help pay my Visa bill though. At least 5.5% is a better return than I'd get from a savings account - although with 13 weeks to go before this account has been open a year, this figure is projected rather than real.
There's nothing to like with this graph.
I don't think I can blame the calling of the snap election for much of my losses this week. IQE:IQE rely on exchange rates at the moment, so a strengthening pound is bad for them, but I think the potential growth in revenues will offset the exchange rate issue. The good news is that TW.:Taylor Wimpey came withing a few quid of going into profit. Nearly a year after Brexit the price has almost recovered and are dishing out big dividends.
The drop in AMYT:Amryt Pharma shouldn't have been a surprise really. The drop in OPTI:Optibiotix was a massive surprise. Long term holders with spare cash are overjoyed they can add a load more to their ISAs. Tragically I don't have either the cash or any shares I want to sell, so all I can do is watch.
Most intriguing event this week is the news that AFPO:African Potash have suspended their shares on the NEX Exchange as they have announced their intention to buy out private company Onshore Energy Ltd. How the hell? They have no money - they have to pay the directors salaries in shares! I guess I shouldn't be too bothered. At the moment my shares are utterly worthless so things couldn't get worse. If this causes something interesting to happen then what the hell. The fact that Executive Chair Chris Cleverly is a director and shareholder of Onshore Energy is a bit of a worry though. The news also confirms there will be fundraising to make the purchase and cover existing running costs. I'm unable to be anything other than suspicious of this company and it's directors, so will watch with an air of skeptical cynicism.
Hope next week isn't as horrid as this one...
Thursday 13 April 2017
Week 88 Review - Fantastic week
Week 88 has been absolutely brilliant. The brilliance was all thanks to AMYT:Amryt Pharma which single-handedly lifted my ISA and Share portfolios into the black for the first time ever yesterday. Overall the total combined portfolios rose by £1,330 to go £3,823 in the black with a total value of £65,046.48 earning 2 "Woohoo!"s for passing £64K and £65K.
It's a real gap!
There was only one double-digit loser this week, and very disappointingly it was SBTX:SkinBioTherapeutics, dropping 20% and below the price I paid for it resulting in a loss of £72. I really thought this would stick at last week's 16p, but it wasn't to be. Never mind eh.
Not many big risers this week either, but a real surprise was RDT:Rosslyn Data climbing 16% in value today. The share price climbed 33% but that only resulted in a 16% reduction in my losses. These are still 56% down on when I bought them.
Star Share this week was mentioned above. AMYT:Amryt Pharma only climbed 4p but that was 34% and added £1,360 to my portfolio value. I shudder to think what will happen if this reaches the broker targets of 88p this year. Highly unlikely, but it would be worth £21,142. Yummy!
The ISA and share accounts look like this
A staggering £1,876 increase in profits, but some deepening losses meant net gain was £1,577. As mentioned above, nearly all this was thanks to AMYT:Amryt Pharma. I tried to bed my JLP:Jubilee Platinum and AMYT:Amryt Pharma shares into my ISA, but for some reason both days I tried it, Hargreaves Lansdown didn't process the order so I cancelled at the end of the day, not wanting to risk it being done on a volatile market day. I'm tempted to just sell AMYT:Amryt Pharma next week and wait the 3 days to transfer the money to my ISA to re-buy, as I suspect there will be a profit-taking dip. But will there??
I've been looking forward to this graph for a long time
Oh unparalleled joy! The green line crashes spectacularly through the red. I don't care how long it stays there - I should frame this and put it on my bedroom wall so I always remember how happy I am right now.
Here's the SIPP after week 72
Most of the losses were IQE:IQE taking an 8% dip, and ARL:Atlantis Resources slipping lower.
Hmm - just a little wobble...
The trading account looks like this after week 38
I hoped to sell KIBO:Kibo Mining this week so I could retrieve the £500 I lent this account and pay off some of my Visa bill, but the hoped-for news didn't materialise so I'll have to wait a bit longer. It was pay day today, so I still paid off the £500 and have a few weeks wiggle room before I need it back.
Nope - that wasn't supposed to happen!
Right - it's Easter now so I'm going to the pub to celebrate one of the best weeks investing ever. I guess "ever" is only 18 months, but it's the happiest I've felt when writing this review.
Another short week next week. Not sure if there's anything particular expected, so we'll just see how things go on Tuesday.
There was only one double-digit loser this week, and very disappointingly it was SBTX:SkinBioTherapeutics, dropping 20% and below the price I paid for it resulting in a loss of £72. I really thought this would stick at last week's 16p, but it wasn't to be. Never mind eh.
Not many big risers this week either, but a real surprise was RDT:Rosslyn Data climbing 16% in value today. The share price climbed 33% but that only resulted in a 16% reduction in my losses. These are still 56% down on when I bought them.
Star Share this week was mentioned above. AMYT:Amryt Pharma only climbed 4p but that was 34% and added £1,360 to my portfolio value. I shudder to think what will happen if this reaches the broker targets of 88p this year. Highly unlikely, but it would be worth £21,142. Yummy!
The ISA and share accounts look like this
| Weekly Change | |||
| Portfolio cost | £42,964.02 | +£0 | |
| Portfolio sell value (bid price - commission) | £43,771.05 | (+1.9%) | +£1,577.75 |
| Potential profits | £5,959.05 | +£1,876.63 | |
| Yr 2 Dividends | £357.10 | +£0 | |
| Yr 2 Profit from sales | £3,314.79 | +£0 | |
| Yr 2 Average monthly cash profit | £438.38 | -£12.99 | |
| Yr 2 Avg annual % of current portfolio cost | 12.2% | ||
| Total Dividends | £1,025.03 | +£0 | |
| Total Profit from sales | £7,155.05 | +£0 | |
| Average monthly cash profit | £398.36 | -£4.76 | |
| (Sold stocks profit + Dividends - Fees / Months) | |||
| Avg annual % of current portfolio cost | 11.1% |
A staggering £1,876 increase in profits, but some deepening losses meant net gain was £1,577. As mentioned above, nearly all this was thanks to AMYT:Amryt Pharma. I tried to bed my JLP:Jubilee Platinum and AMYT:Amryt Pharma shares into my ISA, but for some reason both days I tried it, Hargreaves Lansdown didn't process the order so I cancelled at the end of the day, not wanting to risk it being done on a volatile market day. I'm tempted to just sell AMYT:Amryt Pharma next week and wait the 3 days to transfer the money to my ISA to re-buy, as I suspect there will be a profit-taking dip. But will there??
I've been looking forward to this graph for a long time
Oh unparalleled joy! The green line crashes spectacularly through the red. I don't care how long it stays there - I should frame this and put it on my bedroom wall so I always remember how happy I am right now.
Here's the SIPP after week 72
| Weekly Change | ||||||||||||||||
| Portfolio cost | £16,776.69 | +£0 | ||||||||||||||
| Portfolio sell value (bid price - commission) | £19,910.01 | (+18.7%) | -£227.99 | |||||||||||||
| Potential profits | £3,763.23 | -£187.07 | ||||||||||||||
| Yr 2 Dividends | £0 | +£0 | ||||||||||||||
| Yr 2 Profit from sales | £842.07 | +£0 | ||||||||||||||
| Yr 2 Average monthly cash profit | £174.73 | -£10.94 | ||||||||||||||
| Yr 2 Avg annual % of current portfolio cost | 12.5% | |||||||||||||||
| Total Dividends | £413.19 | +£0 | ||||||||||||||
| Total Profit from sales | £3,191.93 | +£0 | ||||||||||||||
| Average monthly cash profit | £211.78 | -£3.45 | ||||||||||||||
| (Sold stocks profit + Dividends - Fees / Months) | ||||||||||||||||
| Avg annual % of current portfolio cost | 15.1% |
Most of the losses were IQE:IQE taking an 8% dip, and ARL:Atlantis Resources slipping lower.
Hmm - just a little wobble...
The trading account looks like this after week 38
| Weekly Change | |||
| Portfolio cost | £1,481.98 | +£0 | |
| Cash | £79.63 | +£0 | |
| Portfolio sell value (bid price - commission) | £1,365.43 | (-7.9%) | -£19.60 |
| Potential profits | £0 | +£0 | |
| Dividends | £0 | +£0 | |
| Profit from sales | £61.57 | +£0 | |
| Average monthly cash profit | £7.02 | -£0.19 | |
| (Sold stocks profit + Dividends - Fees / Months) | |||
| Avg annual % of current portfolio cost | 5.7% |
I hoped to sell KIBO:Kibo Mining this week so I could retrieve the £500 I lent this account and pay off some of my Visa bill, but the hoped-for news didn't materialise so I'll have to wait a bit longer. It was pay day today, so I still paid off the £500 and have a few weeks wiggle room before I need it back.
Right - it's Easter now so I'm going to the pub to celebrate one of the best weeks investing ever. I guess "ever" is only 18 months, but it's the happiest I've felt when writing this review.
Another short week next week. Not sure if there's anything particular expected, so we'll just see how things go on Tuesday.
Wednesday 12 April 2017
Amryt soars to put ISA and Share accounts in the black
For the first time since I opened a share account in August 2015, the combined ISA and Share accounts are in paper profit.
They have been getting closer all week, but a 14.1% rise in AMYT:Amryt Pharma today caused the paper profits in that share alone to increase by a staggering £1,360. This obliterated all today's small losses throughout the rest of the shares and leaves the combined ISA and Share portfolios up by £1,657 this week and £887 in the black.
The effect on the overall combined portfolios is an increase of £1,470 as the SIPP has dropped a bit, leaving them £3,964 in the black with a value of £65,186. That's two "Woohoo!"s.
Unfortunately tomorrow is a virtual Friday, and we all know what happens on Fridays. Can this last to the end of the week? Can my snapshot graph show the green line crossing the red tomorrow? Pleeeease...
Nearly everything else did rubbish today, with little drops all over the place.
TND:Tandem Group gave an ok set of final results, but they reversed the recent rises and there was a 3.6% drop. The dividend has increased, so I'll keep holding these as I think 8.4 is unfairly low for a P/E ratio so there's room to rise.
Interesting activity at RDT:Rosslyn Data, with an increase of 3.9% on just 3 hefty trades. This is still down by 67% so it would take something fairly spectacular to recover my losses, but with only 75m shares in issue it could move quite quick if anything good happens.
Rather devastating that SBTX:SkinBioTherapeutics dropped below my purchase price today and to £91 paper loss. I really thought this would keep the momentum up and stick around the 16p mark for a while, but nope, I could have bought cheaper if I'd have hung on. OPTI:Optibiotix also dropped again today and is back into loss. KIBO:Kibo Mining, JLP:Jubileee Platinum and IQE:IQE all trickled lower today too.
So, lets keep everything crossed that AMYT:Amryt Pharma stays where it is tomorrow, and the others get back today's losses so we can end the week on an ultra-high for Easter.
They have been getting closer all week, but a 14.1% rise in AMYT:Amryt Pharma today caused the paper profits in that share alone to increase by a staggering £1,360. This obliterated all today's small losses throughout the rest of the shares and leaves the combined ISA and Share portfolios up by £1,657 this week and £887 in the black.
The effect on the overall combined portfolios is an increase of £1,470 as the SIPP has dropped a bit, leaving them £3,964 in the black with a value of £65,186. That's two "Woohoo!"s.
Unfortunately tomorrow is a virtual Friday, and we all know what happens on Fridays. Can this last to the end of the week? Can my snapshot graph show the green line crossing the red tomorrow? Pleeeease...
Nearly everything else did rubbish today, with little drops all over the place.
TND:Tandem Group gave an ok set of final results, but they reversed the recent rises and there was a 3.6% drop. The dividend has increased, so I'll keep holding these as I think 8.4 is unfairly low for a P/E ratio so there's room to rise.
Interesting activity at RDT:Rosslyn Data, with an increase of 3.9% on just 3 hefty trades. This is still down by 67% so it would take something fairly spectacular to recover my losses, but with only 75m shares in issue it could move quite quick if anything good happens.
Rather devastating that SBTX:SkinBioTherapeutics dropped below my purchase price today and to £91 paper loss. I really thought this would keep the momentum up and stick around the 16p mark for a while, but nope, I could have bought cheaper if I'd have hung on. OPTI:Optibiotix also dropped again today and is back into loss. KIBO:Kibo Mining, JLP:Jubileee Platinum and IQE:IQE all trickled lower today too.
So, lets keep everything crossed that AMYT:Amryt Pharma stays where it is tomorrow, and the others get back today's losses so we can end the week on an ultra-high for Easter.
Friday 7 April 2017
Week 87 Review
Trust a Friday to go and mess up my record breaking attempt. Yesterday's gains were zapped and with OPTI:Optibiotix and JLP:Jubilee Platinum both falling further this week, my potential profits have been hit. However, despite Friday's attempts to mess things up, the buffer I had for the week was still strong enough to result in an overall gain of £991, taking the combined portfolios £2,493 into the black with an overall value of £63,716.
I do believe a gap is starting to appear...
Worst performance and only double-digit loser this week was OPTI:Optibiotix, which dropped 10%. I suspect this was mostly down to existing holders selling their shares in order to buy the spin-off SBTX:SkinBioTherapeutics. It battered my potential profits though.
Not double digits, but JLP:Jubilee Platinum fell 8% and also crippled my potential profits, so it's all the more remarkable that everything is up by £991 at the end of the week.
That increase is thanks to a host of great performers. IQE:IQE wasn't double digit, but 8% was very nice. The first double-digit riser was SBTX:SkinBioTherapeutics which rose 13% and vindicated my decision to buy early. It has already wiped out the £90 loss I took to sell VEC:Vectura to raise the cash.
Next great performance was CAML:Central Asia Metals which has been slipping for no real reason lately, but climbed 22% this week to recover nearly all the recent losses.
Star Share was KIBO:Kibo Mining, which was absolutely soaring all week and went from £1,500 loss last week to £245 profit on Thursday. Tragically there was a re-trace today and it dropped 7.5% and back to a £280 loss. Hopefully that was just profit taking and the sentiment that has driven the share in the early part of the week will return next week.
Here's the ISA and share accounts performance
The sale of VEC:Vectura for a £89.44 loss meant the portfolio cost dropped when I bought SBTX:SkinBioTherapeutics, as it was 5th April and I couldn't top up the ISA any more. This affected the average monthly performance too, with bigger drops than usual. I had hoped to bed AMYT:Amryt Pharma and JLP:Jubilee Platinum into my ISA today, but for some reason Hargreaves Lansdown didn't process the order so I cancelled it this evening. I don't want to risk something happening over the weekend that causes massive volatility in the market next week, and let's face it, there's a reasonably good chance of it!
The potential profits were hammered, losing £583 with the drops in OPTI:Optibiotix and JLP:Jubilee Platinum. Most of the improvement that allowed the portfolio value to go up was KIBO:Kibo Mining reducing losses.
It was probably a bit too much to hope for that the green line would meet the red this week. It came so close yesterday, but the gap is only £770 so a recovery in the shares that fell this week could fill that gap quickly.
I've removed the trend lines from the graphs - I decided they didn't really add much and were making it harder to see what was going on.
The SIPP looks like this after week 71
A really good week for the SIPP, mainly thanks to CAML:Central Asia Metals rising 22% and IQE:IQE performing well. That allowed the OPT:Optibiotix and JLP:Jubilee Platinum drops to be swallowed up. Just imagine what a week it would have been if they hadn't dropped!
Back to a widening habit - good to see.
The trading portfolio now looks like this
A good week for a change, mainly thanks to KIBO:Kibo Mining going into profit. I wish I'd sold them on Thursday before the 7.5% drop - must remember this account is meant to be for quick gains, not long term investing. I think I'll avoid selling shares in this account as a live transaction, but when they get to the price I want, I'll put a fairly tight stop-loss on them so I can follow them up if they continue to climb.
There is one thing I have to do with this account, which is get back the third £500 I added. My car cost £800 to get through its MOT today, on the same day I paid a £1,250 deposit on a holiday. The £500 has to plug some of that hole, so when I sell Kibo next week, I'll keep the profit in the account but take out the £500.
Looking much more healthy, and if I'd taken the snapshot yesterday the lines would have crossed
So as usual, as some shares recover others fall. Given all the goings on this week, I'm very pleased with the performance. SBTX:SkinBioTherapeutics has exceeded expectations following IPO and OPTI:Optibiotix CEO Steve O'Hara said that he would consider returning value to shareholders following the spin-off once the shares were up by 20-30%. Well they floated at 9p and are now at 16.25p which I make 80%. That's a lot of profit to Optibiotix who own half the shares. That's why it's a mystery the Optibiotix share price tanked 10% this week.
Let's see how the story unfolds...
Worst performance and only double-digit loser this week was OPTI:Optibiotix, which dropped 10%. I suspect this was mostly down to existing holders selling their shares in order to buy the spin-off SBTX:SkinBioTherapeutics. It battered my potential profits though.
Not double digits, but JLP:Jubilee Platinum fell 8% and also crippled my potential profits, so it's all the more remarkable that everything is up by £991 at the end of the week.
That increase is thanks to a host of great performers. IQE:IQE wasn't double digit, but 8% was very nice. The first double-digit riser was SBTX:SkinBioTherapeutics which rose 13% and vindicated my decision to buy early. It has already wiped out the £90 loss I took to sell VEC:Vectura to raise the cash.
Next great performance was CAML:Central Asia Metals which has been slipping for no real reason lately, but climbed 22% this week to recover nearly all the recent losses.
Star Share was KIBO:Kibo Mining, which was absolutely soaring all week and went from £1,500 loss last week to £245 profit on Thursday. Tragically there was a re-trace today and it dropped 7.5% and back to a £280 loss. Hopefully that was just profit taking and the sentiment that has driven the share in the early part of the week will return next week.
Here's the ISA and share accounts performance
| Weekly Change | |||
| Portfolio cost | £42,964.02 | -£92.97 | |
| Portfolio sell value (bid price - commission) | £42,193.30 | (-1.8%) | +£314.91 |
| Potential profits | £4,082.42 | -£583.43 | |
| Yr 2 Dividends | £357.10 | +£0 | |
| Yr 2 Profit from sales | £3,314.79 | -£89.44 | |
| Yr 2 Average monthly cash profit | £451.37 | -£24.67 | |
| Yr 2 Avg annual % of current portfolio cost | 12.6% | ||
| Total Dividends | £1,025.03 | +£0 | |
| Total Profit from sales | £7,155.05 | -£89.44 | |
| Average monthly cash profit | £403.12 | -£9.20 | |
| (Sold stocks profit + Dividends - Fees / Months) | |||
| Avg annual % of current portfolio cost | 11.3% |
The sale of VEC:Vectura for a £89.44 loss meant the portfolio cost dropped when I bought SBTX:SkinBioTherapeutics, as it was 5th April and I couldn't top up the ISA any more. This affected the average monthly performance too, with bigger drops than usual. I had hoped to bed AMYT:Amryt Pharma and JLP:Jubilee Platinum into my ISA today, but for some reason Hargreaves Lansdown didn't process the order so I cancelled it this evening. I don't want to risk something happening over the weekend that causes massive volatility in the market next week, and let's face it, there's a reasonably good chance of it!
The potential profits were hammered, losing £583 with the drops in OPTI:Optibiotix and JLP:Jubilee Platinum. Most of the improvement that allowed the portfolio value to go up was KIBO:Kibo Mining reducing losses.
It was probably a bit too much to hope for that the green line would meet the red this week. It came so close yesterday, but the gap is only £770 so a recovery in the shares that fell this week could fill that gap quickly.
I've removed the trend lines from the graphs - I decided they didn't really add much and were making it harder to see what was going on.
The SIPP looks like this after week 71
| Weekly Change | |||
| Portfolio cost | £16,776.69 | +£0 | |
| Portfolio sell value (bid price - commission) | £20,138.00 | (+20%) | +£506.61 |
| Potential profits | £3,950.30 | +£496.41 | |
| Yr 2 Dividends | £0 | +£0 | |
| Yr 2 Profit from sales | £842.07 | +£0 | |
| Yr 2 Average monthly cash profit | £185.67 | -£10.31 | |
| Yr 2 Avg annual % of current portfolio cost | 13.3% | ||
| Total Dividends | £413.19 | +£0 | |
| Total Profit from sales | £3,191.93 | +£0 | |
| Average monthly cash profit | £215.23 | -£3.07 | |
| (Sold stocks profit + Dividends - Fees / Months) | |||
| Avg annual % of current portfolio cost | 15.4% |
A really good week for the SIPP, mainly thanks to CAML:Central Asia Metals rising 22% and IQE:IQE performing well. That allowed the OPT:Optibiotix and JLP:Jubilee Platinum drops to be swallowed up. Just imagine what a week it would have been if they hadn't dropped!
Back to a widening habit - good to see.
The trading portfolio now looks like this
| Weekly Change | |||
| Portfolio cost | £1,481.98 | +£0 | |
| Cash | £79.63 | +£0 | |
| Portfolio sell value (bid price - commission) | £1,385.03 | (-6.5%) | +£169.65 |
| Potential profits | £0 | +£0 | |
| Dividends | £0 | +£0 | |
| Profit from sales | £61.57 | +£0 | |
| Average monthly cash profit | £7.21 | -£0.20 | |
| (Sold stocks profit + Dividends - Fees / Months) | |||
| Avg annual % of current portfolio cost | 5.8% |
A good week for a change, mainly thanks to KIBO:Kibo Mining going into profit. I wish I'd sold them on Thursday before the 7.5% drop - must remember this account is meant to be for quick gains, not long term investing. I think I'll avoid selling shares in this account as a live transaction, but when they get to the price I want, I'll put a fairly tight stop-loss on them so I can follow them up if they continue to climb.
There is one thing I have to do with this account, which is get back the third £500 I added. My car cost £800 to get through its MOT today, on the same day I paid a £1,250 deposit on a holiday. The £500 has to plug some of that hole, so when I sell Kibo next week, I'll keep the profit in the account but take out the £500.
So as usual, as some shares recover others fall. Given all the goings on this week, I'm very pleased with the performance. SBTX:SkinBioTherapeutics has exceeded expectations following IPO and OPTI:Optibiotix CEO Steve O'Hara said that he would consider returning value to shareholders following the spin-off once the shares were up by 20-30%. Well they floated at 9p and are now at 16.25p which I make 80%. That's a lot of profit to Optibiotix who own half the shares. That's why it's a mystery the Optibiotix share price tanked 10% this week.
Let's see how the story unfolds...
Thursday 6 April 2017
SkinBioTherapeutics day 2
Great news on day 2, with SBTX:SkinBioTherapeutics climbing 10.4% and into a small profit of £21.
There were only 2.6 million trades today, so far fewer than day 1.
I promise not to report on this every day - but it's the first time I've been invested in a brand new company so I'm excited. I suspect it will wear off by tomorrow.
On checking the trades from yesterday, I discovered I was the 8th person to buy, at 08:00:46hrs. The first person shouldn't count as that was before 8am, so I think I should qualify as the 7th person to buy on the open market.
I'm hoping in 10 years time I'll be able to look back with nostalgia as I explain why the shares that are worth £10 each have made me so much money on a £1,000 investment. That's my daydream anyway.
Elsewhere in the portfolio, today has been spectacular once again, and the combined accounts are £1,670 up this week, which would be a record if it can be sustained to the end of tomorrow. They are now £3,173 in the black and the dreaded ISA and share portfolios are only £232 from break-even. Is it too much to hope that tomorrow will see the green line overtake the red?
Today's £700 climb was largely down to KIBO:Kibo Mining climbing 15.2% and going back into profit of £245. Not bad from a £1,500 loss last week! Ah - the joys of AIM shares. The other big riser was CAML:Central Asia Metals which climbed 4.3% and that's worth a lot.
OPTI:Optibiotix continues to drip slowly downwards, with another 1p gone today and only 2p away from returning to loss. JLP:Jubilee Platinum didn't drop any more today, but is still less than 5p which is a surprise and disappointment.
IQE:IQE finally gave up the relentless climb and dropped 2.7% today, so maybe the dream is over for a while. Not that long ago I would have banked the £3,000 profit, but this one's for the long haul.
So a great day despite some of the big shares having a bad or at least indifferent time.
Fridays have a habit of spoiling a good week, so I wouldn't be surprised if tomorrow has a sting in the tail, but there's a £1,600 buffer on the week performance, so it would have to be a very painful sting to be a spoiler...
There were only 2.6 million trades today, so far fewer than day 1.
I promise not to report on this every day - but it's the first time I've been invested in a brand new company so I'm excited. I suspect it will wear off by tomorrow.
On checking the trades from yesterday, I discovered I was the 8th person to buy, at 08:00:46hrs. The first person shouldn't count as that was before 8am, so I think I should qualify as the 7th person to buy on the open market.
I'm hoping in 10 years time I'll be able to look back with nostalgia as I explain why the shares that are worth £10 each have made me so much money on a £1,000 investment. That's my daydream anyway.
Elsewhere in the portfolio, today has been spectacular once again, and the combined accounts are £1,670 up this week, which would be a record if it can be sustained to the end of tomorrow. They are now £3,173 in the black and the dreaded ISA and share portfolios are only £232 from break-even. Is it too much to hope that tomorrow will see the green line overtake the red?
Today's £700 climb was largely down to KIBO:Kibo Mining climbing 15.2% and going back into profit of £245. Not bad from a £1,500 loss last week! Ah - the joys of AIM shares. The other big riser was CAML:Central Asia Metals which climbed 4.3% and that's worth a lot.
OPTI:Optibiotix continues to drip slowly downwards, with another 1p gone today and only 2p away from returning to loss. JLP:Jubilee Platinum didn't drop any more today, but is still less than 5p which is a surprise and disappointment.
IQE:IQE finally gave up the relentless climb and dropped 2.7% today, so maybe the dream is over for a while. Not that long ago I would have banked the £3,000 profit, but this one's for the long haul.
So a great day despite some of the big shares having a bad or at least indifferent time.
Fridays have a habit of spoiling a good week, so I wouldn't be surprised if tomorrow has a sting in the tail, but there's a £1,600 buffer on the week performance, so it would have to be a very painful sting to be a spoiler...
Wednesday 5 April 2017
SkinBioTherapeutics day 1
A nervous day watching the share price of SBTX:SkinBioTherapeutics today.
My biggest fear was a tank back to the IPO price of 9p following my purchase at 8:01am.
I bought 7,486 shares at 13.9p costing £1,052.50 and with the bid price at 10p was immediately losing £300 on paper.
Fortunately the price settled for much of the day at 13.5p bid and 14p offer, so I was feeling fairly smug that I had got in cheap.
Unfortunately it dropped right at the end of the day to 13p bid and 13.5p offer, so if I'd waited a bit longer I would have been able to buy more.
I don't care really, in fact I'm made up that I would have been one of the first people to buy shares in this company on the open market. It was literally seconds after 8am.
There were 9.8 million shares traded today, which is quite spectacular. It will be very interesting to see how many are traded tomorrow, as people will be filling their ISAs at the start of the new tax year.
I'm planning on bedding some of my share account holdings into my ISA, with the main candidates 6,882 AMYT:Amryt Pharma and 81,087 JLP:Jubilee Platinum. I have high hopes that both these shares will perform well over the next few years, so sheltering them from tax will be a good thing.
It will have an odd effect on my stats. AMYT:Amryt Pharma is £102.23 in profit and JLP:Jubilee Platinum is £377.67 in profit, so it will boost my monthly performance figure, but will lose me £480 from my paper profits.
Fortunately it's been another good day overall, with KIBO:Kibo Mining climbing 9.5% and reducing my paper losses to about £450, which is about £1,000 better off than last week. Amazingly IQE:IQE went up even more, and is now £3,270 in profit. Another big gainer today was REDS:RedstoneConnect, climbing 12.1% after news of a new contract. I've only got this in my trading account, but am becoming increasingly interested as a potential long-term holding.
So the combined portfolio is up by £924 for the week and £2,427 in the black, with the combined ISA and share accounts only £769 in the red and perilously close to break-even. The overall portfolio value has gone over £63,000 so I'm allowed a "Woohoo!".
All eyes on the start of the tax year tomorrow, and will SBTX:SkinBioTherapeutics maintain its value?
My biggest fear was a tank back to the IPO price of 9p following my purchase at 8:01am.
I bought 7,486 shares at 13.9p costing £1,052.50 and with the bid price at 10p was immediately losing £300 on paper.
Fortunately the price settled for much of the day at 13.5p bid and 14p offer, so I was feeling fairly smug that I had got in cheap.
Unfortunately it dropped right at the end of the day to 13p bid and 13.5p offer, so if I'd waited a bit longer I would have been able to buy more.
I don't care really, in fact I'm made up that I would have been one of the first people to buy shares in this company on the open market. It was literally seconds after 8am.
There were 9.8 million shares traded today, which is quite spectacular. It will be very interesting to see how many are traded tomorrow, as people will be filling their ISAs at the start of the new tax year.
I'm planning on bedding some of my share account holdings into my ISA, with the main candidates 6,882 AMYT:Amryt Pharma and 81,087 JLP:Jubilee Platinum. I have high hopes that both these shares will perform well over the next few years, so sheltering them from tax will be a good thing.
It will have an odd effect on my stats. AMYT:Amryt Pharma is £102.23 in profit and JLP:Jubilee Platinum is £377.67 in profit, so it will boost my monthly performance figure, but will lose me £480 from my paper profits.
Fortunately it's been another good day overall, with KIBO:Kibo Mining climbing 9.5% and reducing my paper losses to about £450, which is about £1,000 better off than last week. Amazingly IQE:IQE went up even more, and is now £3,270 in profit. Another big gainer today was REDS:RedstoneConnect, climbing 12.1% after news of a new contract. I've only got this in my trading account, but am becoming increasingly interested as a potential long-term holding.
So the combined portfolio is up by £924 for the week and £2,427 in the black, with the combined ISA and share accounts only £769 in the red and perilously close to break-even. The overall portfolio value has gone over £63,000 so I'm allowed a "Woohoo!".
All eyes on the start of the tax year tomorrow, and will SBTX:SkinBioTherapeutics maintain its value?
SkinBioTherapeutics in the bag
I was poised on the buy button at 1 second past 8 this morning in my quest for SBTX:SkinBioTherapeutics shares.
First press of the button and no quote available. Second quote also not available.
Third press of the button 15p - bugger - oh well, that was the maximum I was prepared to spend so I pressed buy.
Message came back - sale could not be processed - bugger!!
Hit the re-quote button again
Offer came back at 13.9p - yippee!!
Hit the buy button and this time it went through.
Initial feeling of relief and satisfaction.
Soon followed feelings of worry - the IPO price was 9p. Have I paid chronically over the odds?
Massive 30% spread so the holding was losing £300 immediately.
It seems to have settled down now, with a bid price of 13.5p meaning my loss is only £48, and offer price of 14.5p.
All I can do is watch now and see how it ends the day...
First press of the button and no quote available. Second quote also not available.
Third press of the button 15p - bugger - oh well, that was the maximum I was prepared to spend so I pressed buy.
Message came back - sale could not be processed - bugger!!
Hit the re-quote button again
Offer came back at 13.9p - yippee!!
Hit the buy button and this time it went through.
Initial feeling of relief and satisfaction.
Soon followed feelings of worry - the IPO price was 9p. Have I paid chronically over the odds?
Massive 30% spread so the holding was losing £300 immediately.
It seems to have settled down now, with a bid price of 13.5p meaning my loss is only £48, and offer price of 14.5p.
All I can do is watch now and see how it ends the day...
Tuesday 4 April 2017
All ready for SkinBioTherapeutics Launch
VEC:Vectura ticked up a little today, so my loss was reduced to £89.44 (7.3%) when I sold them at lunchtime, but it means I have £1,052.58 ready to invest in SBTX:SkinBioTherapeutics first thing in the morning.
I'm rather nervous about the event. How far will the price have climbed in the first few seconds of trading? Will I even be able to buy on-line? Will I only be able to place a limit order? What's the maximum I'm willing to pay?
So many questions. I was bitten by getting over-excited when I first found out about OPTI:Optibiotix, and bought loads for 90p, which would still be loss-making if I hadn't topped up so many at prices all the way down to 68p. I don't want to make that mistake again, and buy at an inflated price early, only to find it drops 30% for a year.
I think I'll aim for 12p, and if it goes higher then I'll put in a limit order at 12p and see what happens. I can always buy more JLP:Jubilee Platinum in the short term, as that's dropped to a stupid price today, so could be somewhere to rest my money until SBTX:SkinBioTherapeutics sorts itself out. There's just that risk that it will continue to climb and I'll miss my opportunity.
Having said that, OPTI:Optibiotix only had 42 trades all day today, and amazingly most were sells - the day before holders may qualify for free shares in SkinBioTherapeutics! I guess they don't believe we will get free shares. Must admit, I'm beginning to doubt it myself. I just can't believe they would give away 25% of our company without some form of compensation.
Meanwhile it's been another great day today.
CAML:Central Asia Metals issued a superb final results statement, with record output and an increased dividend. What a superb company! The share price went up 5% which was worth hundreds of pounds.
KIBO:Kibo Mining is finally waking up. I don't know whether it's improved sentiment following the UK Investor Show at the weekend, or if news is imminent, but the bid price has gone from 4p to 5p in 2 days and wiped out a big chunk of my losses. They now sit at £814.15 which means Kibo is no longer my Nemesis Share. That title returns to AFG:Aquatic Food and may stay there for a while, as I think only news of buying another company could possibly make this share move.
IQE:IQE never fails to disappoint, climbing another 6.6% and now standing at a potential profit of £3,119.62. The most any share I have ever owned has been in profit. How much further can it go?
That leaves the combined portfolios up £773.43 on the week and £2,275 in the black overall. The ISA and share accounts are now only £828 in the red! Could they finally get into profit? Last time they got this close Trump appeared and everything plummeted, so I will try to temper my excitement.
So, I must steel myself for the morning, finish my daily constitutional a few minutes early and make sure I'm sat at my PC just before 8am so I can be poised to pounce!
I'm rather nervous about the event. How far will the price have climbed in the first few seconds of trading? Will I even be able to buy on-line? Will I only be able to place a limit order? What's the maximum I'm willing to pay?
So many questions. I was bitten by getting over-excited when I first found out about OPTI:Optibiotix, and bought loads for 90p, which would still be loss-making if I hadn't topped up so many at prices all the way down to 68p. I don't want to make that mistake again, and buy at an inflated price early, only to find it drops 30% for a year.
I think I'll aim for 12p, and if it goes higher then I'll put in a limit order at 12p and see what happens. I can always buy more JLP:Jubilee Platinum in the short term, as that's dropped to a stupid price today, so could be somewhere to rest my money until SBTX:SkinBioTherapeutics sorts itself out. There's just that risk that it will continue to climb and I'll miss my opportunity.
Having said that, OPTI:Optibiotix only had 42 trades all day today, and amazingly most were sells - the day before holders may qualify for free shares in SkinBioTherapeutics! I guess they don't believe we will get free shares. Must admit, I'm beginning to doubt it myself. I just can't believe they would give away 25% of our company without some form of compensation.
Meanwhile it's been another great day today.
CAML:Central Asia Metals issued a superb final results statement, with record output and an increased dividend. What a superb company! The share price went up 5% which was worth hundreds of pounds.
KIBO:Kibo Mining is finally waking up. I don't know whether it's improved sentiment following the UK Investor Show at the weekend, or if news is imminent, but the bid price has gone from 4p to 5p in 2 days and wiped out a big chunk of my losses. They now sit at £814.15 which means Kibo is no longer my Nemesis Share. That title returns to AFG:Aquatic Food and may stay there for a while, as I think only news of buying another company could possibly make this share move.
IQE:IQE never fails to disappoint, climbing another 6.6% and now standing at a potential profit of £3,119.62. The most any share I have ever owned has been in profit. How much further can it go?
That leaves the combined portfolios up £773.43 on the week and £2,275 in the black overall. The ISA and share accounts are now only £828 in the red! Could they finally get into profit? Last time they got this close Trump appeared and everything plummeted, so I will try to temper my excitement.
So, I must steel myself for the morning, finish my daily constitutional a few minutes early and make sure I'm sat at my PC just before 8am so I can be poised to pounce!
Subscribe to:
Posts (Atom)